Franklin Resources
MDGL icon

Franklin Resources’s Madrigal Pharmaceuticals MDGL Stock Holding History

Franklin Resources’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5M Sell
9,319
-64,722
-87% -$33.2M ﹤0.01% 1603
2026
Q1 		$38.8M Sell
74,041
-12,035
-14% -$5.75M 0.01% 728
2025
Q4 		$50.1M Buy
86,076
+10,506
+14% +$5.37M 0.01% 641
2025
Q3 		$34.7M Buy
75,570
+14,855
+24% +$5.54M 0.01% 769
2025
Q2 		$18.4M Buy
60,715
+41,762
+220% +$12.4M ﹤0.01% 957
2025
Q1 		$6.28M Buy
18,953
+12,866
+211% +$4.23M ﹤0.01% 1260
2024
Q4 		$1.88M Buy
6,087
+4,704
+340% +$1.32M ﹤0.01% 1751
2024
Q3 		$298K Buy
1,383
+103
+8% +$26.4K ﹤0.01% 2494
2024
Q2 		$359K Sell
1,280
-134
-9% -$31.9K ﹤0.01% 2367
2024
Q1 		$378K Buy
+1,414
New +$333K ﹤0.01% 2381
2023
Q3 		– Sell
-2,984
Closed -$689K – 2742
2023
Q2 		$689K Buy
2,984
+2,096
+236% +$568K ﹤0.01% 1805
2023
Q1 		$215K Buy
888
+114
+15% +$31.1K ﹤0.01% 1981
2022
Q4 		$225K Buy
+774
New +$75.7K ﹤0.01% 1971

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources's MDGL Position: Q2 2026 in Review

Franklin Resources reduced its Madrigal Pharmaceuticals (MDGL) stake by 87% in Q2 2026, selling an estimated $33.2M and leaving 9,319 shares worth $5M. The position accounts for ﹤0.01% of the portfolio, ranked #1603.

Franklin Resources first reported a position in MDGL in Q4 2022 and has held it in 13 quarters since. The position peaked at $50.1M in Q4 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Franklin Resources held 9,319 shares of Madrigal Pharmaceuticals worth $5M as of Q2 2026.
  • Franklin Resources sold 64,722 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $33.2M.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #1603 holding.
  • Franklin Resources first reported a position in Madrigal Pharmaceuticals in Q4 2022 and has held it in 13 quarters since.
  • Franklin Resources's Madrigal Pharmaceuticals position peaked at $50.1M in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.